XKEM chart analysis and DD

[up2nogd420]

Anyone still following this one? Tomorrow should be quite interesting to say the least. It appears the bottom has been set and a reversal is underway. Massive volume has poured in the past 2 days along with an amazing eod run Friday. Have a look at the chart…

http://stockcharts.com/h-sc/ui


On Thursday, 6/01/2006, the company put out a PR announcing it has successfully closed on a $1.2 million loan…
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B5D99541C%2DEE49%2D4042%2DA3D3%2 DEC21CCC3321A%7D&siteid=mktw&sid=1456132&symb

And also filed this 8-K…
http://edgar.brand.edgar-online.com/fetchFilingFrameset.aspx?FilingID=4457555&Type=HTML

Here is the website of the manufacturing facility where Nicosan will be produced…
http://www.shestco.org/tech_park.htm

Check out this article written about 3 months ago…
http://www.businessdayonline.com/?c=44&a=4926

Here’s some older news…

Xechem Files Orphan Drug Application with the FDA…
http://biz.yahoo.com/bw/060314/20060314005285.html?.v=1

Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers Squibb…
http://www.xechem.com/012406.html

Xechem Completes Repurchase of $3 Million Convertible Loan From Alembic…
http://www.xechem.com/011206.html

Here some websites for the company…
http://www.xechem.com/
http://www.xechemnigeria.org/


All the pieces of the puzzle are now falling into place. Here is one last quote from last Thursdays PR in case you missed it…

“Drug To Be Launched In Nigeria Following NAFDAC Approval

As previously reported by Xechem International, Xechem Nigeria has submitted its Drug Master File (DMF) dossier with Nigeria's drug regulatory agency, the National Agency for Food and Drug Administration and Control (NAFDAC), seeking full registration for NICOSAN(TM). It is currently awaiting final word from that agency on its submission. Subject to the necessary approvals, Xechem has indicated that it would like to launch the drug in Nigeria by early July 2006, and shortly thereafter to embark on the clinical trials in the US hospitals for FDA approval through the Investigational New Drug (IND) Application for sale of the drug in the United States.”

NAFDAC approval is just around the corner, it’s only a matter of time. Good luck to everyone playing this!

[up2nogd420]

Up 45% so far today. There is some major volume pouring into this one. I would not be surprised to see another eod rally like the one on Friday.

[up2nogd420]

http://www.prophet.net/analyze/scauth.jsp?symbol=XKEM&width=1049&height=400&price.display=3&duration=3d&interval=1&price.scale=1&VOL=&redbars=1&hideevents=1&barsofar=1&&scheme=blugray&snapquote=1&service=ProphetSnapCharts&scsave=1&randomize=0.6278099378581281


Another great day today! XKEM finished strong once again, up 62.5% with a record 250 million shares traded. Over 6.4 Million dollars traded hands. Not bad for a penny stock currently trading under 3 cents. XKEM is listed as the most active stock traded on the OTCBB today. Something is definitely brewing here people. NAFDAC approval appears to be eminent at this point.

[TheChartGuru]

It has resistance at .029. I'm surprised that it didn't break out with such huge volume today. It is a buy if it breaks out of .03. If it doesn't break out, it is going back down again below .02. IMHO

The Guru has spoken

[TheChartGuru]

It has resistance at .029. I'm surprised that it didn't break out with such huge volume today. It is a buy if it breaks out of .03. If it doesn't break out, it is going back down again below .02. IMHO

The Guru has spoken

[TheChartGuru]

Oops, I was looking at Mad Girl's nude shot and got distracted and hit the reply button twice. Sorry for the double post.

The Guru has spoken

[Mad Girl Investor]

Gee, what an effect my peaches has on people!

[chinaman711]

News out today could get xkem going again

[TheChartGuru]

My apologies. I don't know what chart I was reading last night but I gave you some false information! Yes, resistance is at .029 but the close yesterday was at .016. So there is still lots of headroom. Looks like it can run for a couple of days. Boy those Mad Girl nude shots are really distracting me!

The Guru has spoken

[stockviper]

Seems to be creeping up after lunch. May just break .030 EOD.

[NavyPilot]

XKEM closed today around 3 cents today. Any thoughts on target price? TIA

[NavyPilot]

XKEM closed around 3 cents (31.22%) today. Any thoughts on target price? TIA

[stockviper]

Found this on another board. Someone did a ton of DD about XKEM.

For those of you who have some spare time, I hope you can get some valuable info out of this.

Speculative interpretations and dissertation on XKEM.

The Big Question:

As of late, as we all sit lying awake at night, hoping and praying for Nigerian approval of Xechem's SCD drug, Nicosan, many questions have been asked from one stock board to another about XKEM and its relationship to Marjorie Chassman and, as well, the validity of XKEM itself. Who is this woman? Is she some ultra-rich financier who has a steadfast head for investing large sums of money into indebted biotech companies in an era when biotech has long since passed its peak? Is she richer and smarter than the world's banking industry itself? Can her financing actually enable the smaller investors to predict the future? The short answer is, no.

Along with all the other XKEM hype, Marjorie Chassman begs the biggest question of them all: Looking into the near future, if Xechem is such an incredible company with so much promise that (as shareholder board posts would have one believe) it simply cannot be denied, then why cannot this company, over the course of so many years (since its inception in the early 90s) acquire real loans from real banks to be paid back with real profits? And why must XKEM look to such "generous" individuals as Margie Chassman for a majority of its loan structure/value, while continuing to increase its float and reverse split, since before and after the turn of the century?

One answer and one name: DAVID BLECH

Has anyone ever heard of the famously coined phrase, "Blech Thursday"?
It was a phrase coined in the early/mid 90s that came to symbolize the end of the biotech era as it was once known.
And David Blech's name is synonymous with that end.

David Blech was an upstart and ambitious venture capitalist who sprung essentially from nowhere (he was a songwriter and 'entrepreneur') in the late 80s with $10,000 in his pocket and big dreams. He started multiple companies in the biotech industry and a few years later was worth over the hundred million dollar mark. (Bristol Meyers bought one of his companies, Genetech Systems, for $294 million only later to do their own DD, find out its true value was practically zilch, and sell it away for a paltry $20 million -- "taking a $274 million dollar bath") http://www.findarticles.com/p/articles/mi_m1316/is_n8_v21/ai_7939775

Long story short, (you can do the DD yourself with the links i've provided and with everything else that's out there), but upon the collapse of the biotech boom, Blech was eventually filed suit against by numerous private and public companies, individuals, class-action suits and, of course, the SEC. Longer story shorter: he plead guilty to a mass of charges brought against him and/or plead out and eventually turned 'informant' on those he'd conspired with in exchange for leniency by the Feds.

So, how XKEM found the ever-generous Marjorie Chassman to loan them all this money (millions upon millions) over so many years while the company showed nothing but debt has but one best guess: through David Blech.
How'd that come to be you may ask? Simple... Chassman and Blech are married.

As the Seattle Times reported: at the onset of his downfall, when Blech's first wife discovered he was forging her signature for false purposes, she divorced him immediately. His second wife, Marjorie Chassman, was reported to be "a graphic designer and aspiring actress" who was supporting him at the time of his demise. http://seattletimes.nwsource.com/uninformed_consent/financier/story1.html

So, again, it begs the question: How would his second wife, Marjorie Chassman (a graphic designer and aspiring actress) have the know-how and savvy to get involved in the vast and complicated world of loaning indebted companies millions and trading in public securities to great personal gain (of which thus far i have found 3: NVLT.OB, CEPO.OB and SCLL.OB). Answer: Through her husband and "partner-in-speculatively-questionable-activity", David Blech.

And, guilty as charged, David Blech is (squirm) involved in XKEM and may very well be the leader of this big parade.

Direct Link between XKEM and BLECH: http://www.littleindia.com/archive/dec96/survive.htm
Excerpt: "On Nov 19 (1996-ish), Xechem announced that a group controlled by David Blech, a well-known but controversial investor in the biotechnology industry, will invest $5.5 million in the company over the next nine months. As a result of the deal, Blech and his associates will replace Pandey as Xechem's controlling shareholders, with a stake of more than 70 percent. Pandey, however, will remain the CEO as well as the second-largest shareholder. He is delighted at the deal because the capital infusion will allow Xechem to develop products that he believes could become big winners in the future. "With Blech's investment and expertise, our future is very bright," he says. "In the next three to five years, we could have sales of $30 million to $50 million.""

Those sales predictions came in 1996 for the future of 1997. Well, we all know that didn't happen as the loans continue today and XKEM continues to show massive losses.

Note XKEM / Chassman / Blech link:
While many on the boards are speaking zealously how the debt owed by XKEM will not have to be paid until 2008, please note the paragraph below from this link: http://biz.yahoo.com/e/050623/xkem.ob8-k.html
Excerpt: "For the period from November 11, 2003 through June 30, 2004, Marjorie Chassman, the spouse of David Blech ("Chassman") advanced $2,800,000 of convertible debt to Xechem, which debt accrued approximately $320,884 in interest (as of June 20, 2005) and is due and payable December 31, 2006, subject to the required sale of Xechem's holdings of CepTor Stock."
(the CepTor deal is an entirely other issue)
Blech's shady past:
http://www.bearstearnsfraudinfocenter.com/information.php
Excerpt: "The case was a $77 million class action lawsuit filed against Bear Stearns on behalf of investors who claimed they had lost their money due to the fraudulent actions of David Blech, a Bear Stearns client. The judge stated that a summary judgment could not be made because there were not enough facts available to determine if Bear Stearns was guilty or not. Bear Stearns said that it had no knowledge of Blech’s stock manipulating (he pled guilty to charges of fraud in 1999). The investors who lost their money to Blech want to convince the jury otherwise."

Link demonstrating Chassman/Blech relationship:
http://freeadvice.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?S essionID=qYy_S2bI2EMWcJ4&ID=4327914
Excerpt: "In January 2005, we entered into an agreement with David Blech (the husband of Margie Chassman), which provided that he or his designees would lend us $500,000 (inclusive of $100,000 previously advanced to us in December 2004 by Ms. Chassman) for operating capital pending our debt restructuring and completion of our private placements of units, and up to an additional $500,000 on the same terms if the private placement was delayed.... The two loans, both of which were made by Ms. Chassman, totaled $500,000 and bore interest at 6% per annum.... According to the agreement, we also issued the following individuals the following number of shares of our common stock:



Investor

Number of Shares
of Common stock
Margie Chassman


2,475,000

Wood River Trust


3,850,000

Esther Blech


1,225,000

Milton Chassman


1,225,000

Aaron Eiger


1,225,000

Mark Germain


500,000


Wood River Trust is a trust formed for the benefit of Evan Blech, the son of Ms. Chassman and Mr. Blech. The trustees of the trust are Harvey Kesner and Michael C. Doyle (no relation to our director, Michael J. Doyle). Esther Blech is the mother-in-law of Ms. Chassman. Milton Chassman is the brother of Ms. Chassman. These investors have agreed not to publicly sell their shares of common stock until November 2006 and if they sell their shares in a private transaction, the buyer must also agree not to sell their shares publicly until November 2006."

(The whole family's in on that one!)

So why go through all the trouble and take such HUGE risks on an indebted company with a very questionable future? There's millions of reasons (literally). One speculative scenario: Get in at the beginning and loan a company money that you know can't pay you back (resulting in consistently debt-ridden quarterly public financial statements) in exchange for huge amounts of shares (often times valued at far lower than the current PPS) and SHORT, SHORT, SHORT, in which case after the inevitable reverse splits come (3000:1 in XKEM's case in May of '03) and an ever-increasing float bears down on shareholders, those who have put themselves in a short position stand to make nearly incalculable gains. Bear this in mind: XKEM's initial IPO was $5 a share and it went as high as $13. It's now doing everything it can to stay above .03.

Other companies who are involved with Chassman and Blech also have troubling outlooks:
--In mid-August of 2005 NVLT.OB (another Chassman/Blech involved company) was at $4.47 a share. Today, it's worth .95c.
--In mid-February of 2005 CEPO.OB (another Chassman/Blech involved company) was at $6.75 a share. Today, it's worth .24c.

How did Blech do it? http://www.sec.gov/news/digest/02-07.txt
Excerpt: "From approximately June through September 1994, David Blech, the chief executive officer of D. Blech & Co., orchestrated a massive manipulative scheme designed to increase or stabilize the prices of a number of the biotechnology securities for which D. Blech & Co. was a market maker. As part of this scheme, David Blech routinely sold biotechnology stocks from D. Blech & Co.'s inventory accounts to brokerage accounts that Blech controlled that were in the names of other individuals and entities. These controlled accounts then sold the biotechnology stocks back to the brokerage firm or to other accounts controlled by David Blech. These trades created the appearance of active trading in the biotechnology stocks. Additionally, through this trading, Blech was able to reduce D. Blech & Co.'s inventory position in the biotechnology stocks, yet still artificially withhold from the market the supply of the biotechnology stocks."

So, with XKEM, how many shares of this roughly 1.3 billion O/S count do we all REALLY own? Long. For Real. No Flipping? Your guess is as good as mine.

The most recent official audit I was able to find was released in 2003 and noted the following:
Excerpt from: http://yahoo.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?Sessio nID=rQRcI4St_vooX3Y&ID=3527233

REPORT OF INDEPENDENT ACCOUNTANTS
To the Audit Committee of Xechem International, Inc.
We have audited the accompanying consolidated balance sheet of Xechem International, Inc. and Subsidiaries (a Development Stage Company) as of December 31, 2002 and the related consolidated statements of operations, stockholders' equity and cash flows for the period ended December 31, 2002. The consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the consolidated financial statements based on our audit.
We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statements presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Xechem International, Inc. and Subsidiaries (a Development Stage Company) as of December 31, 2002 and the consolidated results of their operations and their consolidated cash flows for the period ended December 31, 2002 in conformity with accounting principles generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred substantial losses and negative cash flows since inception through the period ended December 31, 2002, had a working capital deficiency, and have realized minimal revenues to date. The Company's historical losses and illiquid financial position raise substantial doubt about the Company's ability to continue as a going concern.
WISS & COMPANY, LLP ?Livingston, New Jersey ?March 6, 2003

While that audit is a few years old, it essentially predicted XKEM's true future and present condition at this time. Leaving nothing said of the begging questions of XKEM, Margie Chassman and David Blech's relationship and Blech's shady past, there's definitely more to this story than I've uncovered and certainly much more that will never be told.

So why go through all the trouble and take such HUGE risks on an indebted company with a very questionable future? There's millions of reasons (literally). One speculative scenario: Get in at the beginning and loan a company money that you know can't pay you back (resulting in consistently debt-ridden quarterly public financial statements) in exchange for huge amounts of shares (often times valued at far lower than the current PPS) and SHORT, SHORT, SHORT, in which case after the inevitable reverse splits come (3000:1 in XKEM's case in May of '03) and an ever-increasing float bears down on shareholders, those who have put themselves in a short position stand to make nearly incalculable gains. Bear this in mind: XKEM's initial IPO was $5 a share and it went as high as $13. It's now doing everything it can to stay above .03.

Other companies who are currently involved with Chassman and Blech also have troubled outlooks:
--In mid-August of 2005 NVLT.OB (another Chassman/Blech involved company) was at $4.47 a share. Today, it's worth .98c.
--In mid-February of 2005 CEPO.OB (another Chassman/Blech involved company) was at $6.75 a share. Today, it's worth .20c.

[up2nogd420]

Jackpot!


http://www.thisdayonline.com/nview.php?id=50861


Good luck guys!

[stockviper]

just bounced over .05!

[stockviper]

Just sold some losing crap (STTK) and figured I'd through the money onto XKEM. Just got another 5000 shares. Hopefully I'll make some money to make up for the previous loss.

Watch... XKEM will go down and the crap I sold will rocket up!

[mpatel]

Hopefullly not, XKEM is looking strong without any PR
looks like Monday there could be PR
83 mil traded already in an hour... receiving alot of attention

[stockviper]

Jumped above .07. YIKES!

[mpatel]

Wow nice open
gapped up from .059 to .07
volume is pouring in
Ive noticed this stock rising until lunch time and it goes back down, after lunch it takes off again

Im thinking about flippin this one
GL to everyone that held on to this one, we could be in for a nice ride

[stockviper]

Pullback today with the slow market. May be a good time to buy more.

[InvestingMoron]

I saw XKEM go from .0505 to .0585 in front of my eyes. Could have made a quick buck, but hey. Good call.

[mpatel]

I missed the big dig, that dropped low in the 4s. I had to settle with .052. It had some great volume today as we saw it go from 0.64 down to .043 and close at .059. Even on a off day someone made a nice chunk of cash

[stockviper]

So far so good today. We are headed up again.

[stockviper]

Still going up! I bought more today and then it dropped a little. I should have waited but just in case anyone isn't paying attention now may be a good time to jump in with the slight dip. .095 ish...

[mpatel]

PR has been released. THe drug has been approve by Nigeria. Looks like everybody wanted to take their profits. IT was up around .11 most of the day and then this thing went from .105 down to .075 in the last 30 min of the day. Talk about tanking.... Hopeufully it recovers.

[stockviper]

Yes, that was nuts...but I just don't understand...pure profitaking I hope and maybe panic selling drove it down more but I have to believe it's just a hickup (a big one). This morning I noticed a gap up and said to myself it won't come back...sure enough it filled the gap and then some.

Tomorrow will be better...I'm saying that because I feel most of the panic panic sellers are gone. Now that the price is lower the true believers will be clammering to buy more.

Time will tell. I've been wrong before. When you stop learning, somethings wrong.

[Mad Girl Investor]

Buy rumor, sell news. The rumor mill drove it up 100"s of percent over a week to 10 days of trading. It dived in last 30 mins only,,think it has more diving to do. It was a freaking day traders dream today. I know a guy who flipped it 8 times today,,,in a chat room, he followed it and posted his round trips...8 times!

Be careful, guys, follow intraday charts to see where bottom of dip is.

Good luck.

[up2nogd420]

As far as tomorrow goes, the chart doesn’t look so good…Unless you’re able to daytrade. I really need to get that margin paperwork filled out! I could see this thing bouncing anywhere between $.05 & $.11 tomorrow. Today was yet another recording breaking day in volume, and I expect tomorrow and the coming days/weeks will have similar volatility. Today appeared to be the ol’ classic buy on rumor/sell on news type of trading. Not that anyone cares, but I haven’t sold a share yet. I’ve been holding every share since I started this thread 1 month ago today. I take absolutely no credit for this one, I just happen to stumble upon it a few months back on some other message board. I just thought I would share some DD for those interested on this relatively laid back forum which I enjoy very much. Since then this stock has gone up over 500%. This is my first penny stock ever. I always read warnings how you shouldn’t fall in love with a stock. I’m not quite in love but very happy at the time being (today did suck though…good thing I was away at school and didn’t get to see it tank on the great news...I can only imagine how the people who bought at $.11 feel!!!). Unless this thing goes below $.03, I’m not the least bit worried. Take a look at the 3 year chart…The trend is up from here out. I could definitely see this in the .20’s within the next month. In case you all missed the news this afternoon, here it is…

July 5, 2006 - 2:26 PM EDT

Xechem Receives Approval For Sale Of NICOSAN(TM) From Nigerian Regulatory Authorities -- NAFDAC

Xechem International, Inc. (OTC BB: XKEM). Xechem International announced today that its subsidiary, Xechem Pharmaceuticals Nigeria, has received approval on July 3rd, 2006 from Nigeria's drug regulatory authority, the National Agency for Food and Drug Administration and Control (NAFDAC), for the marketing and sale of NICOSAN(TM), for the prophylactic management of Sickle Cell Disease (SCD). The approval is for an initial term of two years, which will allow Xechem to complete confirmatory Phase III clinical trials in Nigeria. The company faces no restrictions on its ability to market and sell the drug in Nigeria.
President Obasanjo To Launch NICOSAN(TM) at Xechem Nigeria's Corporate Headquarters
His Excellency, President Olusegun Obasanjo, the President and Commander in Chief of the Federal Republic of Nigeria, is expected to officially launch NICOSAN(TM) at a ceremony to be held on July 6th, 2006 at the headquarters of Xechem Pharmaceuticals Nigeria. A number of other dignitaries, business leaders and governmental officials are also scheduled to attend the launch.
According to Dr. Ramesh Pandey, the Chairman and CEO of both Companies, NAFDAC's approval of NICOSAN(TM) represents a monumental and historical achievement for Xechem and the great people of Nigeria. Xechem is grateful to the many people whose tireless efforts have made this day possible. Sickle Cell Disease is a devastating and debilitating disease for which there has never been an effective treatment on the market. Finally, we can say categorically that is no longer the case. To bring this drug to market first in Nigeria, a country with by far the largest sickle cell population in the world and whose scientists originally developed the medicine, from historical herbal remedies, is particularly gratifying. For sickle cell sufferers in Nigeria, the wait is over. Soon, we hope that will be the case for other countries of the world."



I’m too exhausted to go into anymore detail about XKEM so I'm just going to share this great informative post i found on another board which pretty much sums it all up. I couldn't explain it any better than this. Please take it for what its worth…and good luck to all!!!



*** XKEM MARCHING TO ITS market value ***

The PAIN of those who sold late today on "MM manipulation" will start tomorrow.

All what the LONGS have been saying is now confirmed.

The masses will become more aware of this GEM on every passing day.

Xechem Receives Approval For Sale Of NICOSAN(TM) From Nigerian Regulatory Authorities -- NAFDAC

The company faces no restrictions on its ability to market and sell the drug in Nigeria.

http://biz.yahoo.com/bw/060705/20060705005761.html?.v=1

Hold on tight to those precious XKEM shares.

Expected short term PR list.
----------------------------
PR#1 - Non-dilutive 8.2 Million Dollar loan.
PR#2 - Start of production.
PR#3 - Exporting to other countries

Time is running out to get into this GEM.

Follow the SMART money ... which continues to buy heavily.
14.6 Million last Friday,
7.8 Million last Monday,
6.0 Million last Tuesday,
9.6 Million last Wednesday
7.6 Million last Thursday
4.3 Million last Friday
7.7 Million on Monday (on a half day trading)
21.7 Million on Tuesday (a new record)
=====
79.3 Million in last 8 trading days.

http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=8&x=21&y=27

For a penny stock ... that's an amazing amount of CASH flowing into this stock.

*** FOLLOW THE MONEY ***

Bank wants to double their initial investment (for good reason)
http://www.cometnewsonline.com/capital.html

With latest 8K, OS is now confirmed at 1.2B.

In Nigeria alone, there are 4,000,000 SCD patients.

NICOSAN™ $20/month (conservative) = $240/year

$240 x 4,000,000 SCD patients = $960,000,000 US dollars.

Let’s assume at least 50% margins.

Earnings = $480,000,000

Price-Earnings Ratio - P/E Ratio
http://www.investopedia.com/terms/p/price-earningsratio.asp

The P/E is sometimes referred to as the "multiple", because it shows how much investors are willing to pay per dollar of earnings. If a company were currently trading at a multiple (P/E) of 20, the interpretation is that an investor is willing to pay $20 for $1 of current earnings.

Now lets take BRISTOL MYERS SQIBB (BMY)
BMY has a P/E of approximately 15 and a market CAP of $$$ 49 Billion $$$.

Oh yes, didn't XKEM just win a 4 Million Dollar law suit against the BMY giant. See for yourself. (Impressive indeed)
http://www.marketwire.com/mw/release_printer_friendly?release_id=104501&category=

$480,000,000 * 15 = approx $7,000,000,000

Divide by the number of outstanding shares
(approx 1.2 Billion)

$14,000,000,000 / 1,200,000,000 = $11.60

Now let's say they only get to sell to 10% of the people at first.

Why only 10 percent you ask?
- Difficulty to ramp up production at first.. However the demand is there, just need to get production to the level of the demand.
(Imagine opening a business where your sales are already pre-determined and waiting for you to simply act on them)

Let’s not forget how this will improve the lives of millions of sufferers and the publicity that it will create.

This is a WIN WIN for all involved.

10% of $11.60 = $1.10 stock..

Now add the rest of Africa (another 5 million cases)
(as production increases)

easy double.. $2.20

Now export the drug to the rest of the world....

Over time, allow the production to ramp up & increase sales from 10% to 50%

Still want to give away your shares under 1.00 ? (and before the imminent PR’s above)

This is a 400 Million dollar company at approval time.. and it will rise from there at a slower pace as reality sets in.

Some past PR's..
================
Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF 6 Jun 2006 (BusinessWire)

Xechem's Subsidiary -- Xechem Pharmaceuticals Nigeria -- Receives N150 Million Naira... 1 Jun 2006 (BusinessWire)

Xechem Files Orphan Drug Application with the FDA For The Anti-Sickling Compound... 14 Mar 2006 (BusinessWire)

Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers Squibb 25 Jan 2006 (BusinessWire)

Xechem Completes Repurchase of $3 Million Convertible Loan From Alembic; Alembic... 12 Jan 2006 (BusinessWire)

Xechem Receives $560,000 From Sale Of New Jersey State Net Operating Losses 29 Dec 2005 (BusinessWire)

Xechem Settles Antitrust Lawsuit Against Bristol-Meyers Squibb for $4.2 Million 20 Dec 2005 (BusinessWire)

Xechem Expands its Arsenal for Treating Sickle Cell Disease; Licenses New Anti-Sickling... 9 Dec 2005 (BusinessWire)

[soundlanguage]

As far as tomorrow goes, the chart doesn’t look so good…Unless you’re able to daytrade. I really need to get that margin paperwork filled out! I could see this thing bouncing anywhere between $.05 & $.11 tomorrow. Today was yet another recording breaking day in volume, and I exp Unless this thing goes below $.03, I’m not the least bit worried. Take a look at the 3 year chart…The trend is up from here out. I could definitely see this in the .20’s within the next month. In case you all missed the news this afternoon, here it is…



Nice pick, thanks for sharing. I completely missed this action today actually but
seems plenty were having a good ride. Did you notice that intense volume in after
hours trading? Click below.

Might see an early run up, then who knows... btw, funny handle.
(trade easy while 420ing or you might lose all your magic beans)

http://www.marketwatch.com/tools/quotes/intchart.asp?symb=XKEM&intflavor=basic

[stockviper]

I got out this morning with a nice profit and have 2500 free shares to let ride. I'll stop worrying about this one for a while and check it in a few weeks.

[dilan_1]

How far it going togo down. It's time to go in or not it. Anybody still playing with it.

[stockviper]

Press release coming out tomorrow. Maybe that will get it going up again?

[dilan_1]

I hope it going to be good news for company. I loss a lot of money on it. I not jumped out of trend in time.

[dilan_1]

Anybody knows about news coming up.:?